Ezetimibe manufacturers in India
With considerable effort towards R&D, we have already assigned a target CAGR of 10-15% per year and an ambitious plan to develop 15-20 molecules for DMF filing. Our company collaborates directly with CMOs to develop new products along with managing product life cycles.